Treatment of Ewing's sarcoma in the cooperative Ewing's sarcoma study group

Toshihumi Ozaki, Winfried Winkelmann, Normann Willich, Herbert Jürgens

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Multidisciplinary treatment approaches have greatly improved the prognosis of patients with Ewing's sarcoma. Four- or five-drug combination chemotherapy regimens are combined with radiation and/or surgery for local control. Currently, in the Cooperative Ewing's Sancoma Study (CESS) trials, approximately 60% of the protocol patients with Ewing's sarcoma show a relapse-free 10-year survival. For improvement of local control, preoperative radiotherapy and/or brachytherapy may be helpful. The early detection of blood and/or bone marrow contamination by molecular diagnosis can lead to a new clinical staging system. A myeloablative regimen consisting of simultaneous total body irradiation and chemotherapy may improve the prognosis of patients with disseminated disease.

Original languageEnglish
Pages (from-to)180-184
Number of pages5
JournalJournal of Orthopaedic Science
Volume2
Issue number3
DOIs
Publication statusPublished - 1997

Fingerprint

Ewing's Sarcoma
Whole-Body Irradiation
Brachytherapy
Drug Combinations
Combination Drug Therapy
Radiotherapy
Therapeutics
Bone Marrow
Radiation
Recurrence
Drug Therapy
Survival
Pharmaceutical Preparations

Keywords

  • Chemotherapy
  • Ewing's sarcoma
  • Prognosis
  • Radio-therapy
  • Surgery

ASJC Scopus subject areas

  • Surgery

Cite this

Treatment of Ewing's sarcoma in the cooperative Ewing's sarcoma study group. / Ozaki, Toshihumi; Winkelmann, Winfried; Willich, Normann; Jürgens, Herbert.

In: Journal of Orthopaedic Science, Vol. 2, No. 3, 1997, p. 180-184.

Research output: Contribution to journalArticle

Ozaki, Toshihumi ; Winkelmann, Winfried ; Willich, Normann ; Jürgens, Herbert. / Treatment of Ewing's sarcoma in the cooperative Ewing's sarcoma study group. In: Journal of Orthopaedic Science. 1997 ; Vol. 2, No. 3. pp. 180-184.
@article{c51454fa51c54c438f3559f8f9d74b3b,
title = "Treatment of Ewing's sarcoma in the cooperative Ewing's sarcoma study group",
abstract = "Multidisciplinary treatment approaches have greatly improved the prognosis of patients with Ewing's sarcoma. Four- or five-drug combination chemotherapy regimens are combined with radiation and/or surgery for local control. Currently, in the Cooperative Ewing's Sancoma Study (CESS) trials, approximately 60{\%} of the protocol patients with Ewing's sarcoma show a relapse-free 10-year survival. For improvement of local control, preoperative radiotherapy and/or brachytherapy may be helpful. The early detection of blood and/or bone marrow contamination by molecular diagnosis can lead to a new clinical staging system. A myeloablative regimen consisting of simultaneous total body irradiation and chemotherapy may improve the prognosis of patients with disseminated disease.",
keywords = "Chemotherapy, Ewing's sarcoma, Prognosis, Radio-therapy, Surgery",
author = "Toshihumi Ozaki and Winfried Winkelmann and Normann Willich and Herbert J{\"u}rgens",
year = "1997",
doi = "10.1007/BF02492975",
language = "English",
volume = "2",
pages = "180--184",
journal = "Journal of Orthopaedic Science",
issn = "0949-2658",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Treatment of Ewing's sarcoma in the cooperative Ewing's sarcoma study group

AU - Ozaki, Toshihumi

AU - Winkelmann, Winfried

AU - Willich, Normann

AU - Jürgens, Herbert

PY - 1997

Y1 - 1997

N2 - Multidisciplinary treatment approaches have greatly improved the prognosis of patients with Ewing's sarcoma. Four- or five-drug combination chemotherapy regimens are combined with radiation and/or surgery for local control. Currently, in the Cooperative Ewing's Sancoma Study (CESS) trials, approximately 60% of the protocol patients with Ewing's sarcoma show a relapse-free 10-year survival. For improvement of local control, preoperative radiotherapy and/or brachytherapy may be helpful. The early detection of blood and/or bone marrow contamination by molecular diagnosis can lead to a new clinical staging system. A myeloablative regimen consisting of simultaneous total body irradiation and chemotherapy may improve the prognosis of patients with disseminated disease.

AB - Multidisciplinary treatment approaches have greatly improved the prognosis of patients with Ewing's sarcoma. Four- or five-drug combination chemotherapy regimens are combined with radiation and/or surgery for local control. Currently, in the Cooperative Ewing's Sancoma Study (CESS) trials, approximately 60% of the protocol patients with Ewing's sarcoma show a relapse-free 10-year survival. For improvement of local control, preoperative radiotherapy and/or brachytherapy may be helpful. The early detection of blood and/or bone marrow contamination by molecular diagnosis can lead to a new clinical staging system. A myeloablative regimen consisting of simultaneous total body irradiation and chemotherapy may improve the prognosis of patients with disseminated disease.

KW - Chemotherapy

KW - Ewing's sarcoma

KW - Prognosis

KW - Radio-therapy

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=0030917423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030917423&partnerID=8YFLogxK

U2 - 10.1007/BF02492975

DO - 10.1007/BF02492975

M3 - Article

VL - 2

SP - 180

EP - 184

JO - Journal of Orthopaedic Science

JF - Journal of Orthopaedic Science

SN - 0949-2658

IS - 3

ER -